Filing Details

Accession Number:
0001181431-10-063549
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-23 18:18:54
Reporting Period:
2010-12-21
Filing Date:
2010-12-23
Accepted Time:
2010-12-23 18:18:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382911 Orexigen Therapeutics Inc. OREX Pharmaceutical Preparations (2834) 651178822
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202793 Michael Powell C/o Sofinnova Ventures
850 Oak Grove Ave
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-12-21 309,730 $8.38 371,184 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-21 61,405 $8.38 73,376 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-21 4,204 $8.38 5,101 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-22 206,895 $8.30 164,289 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-22 41,018 $8.30 32,358 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-22 2,808 $8.30 2,293 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-23 164,289 $8.09 0 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-23 32,358 $8.09 0 No 4 S Indirect See footnote.
Common Stock Disposition 2010-12-23 2,293 $8.09 0 No 4 S Indirect See footnote.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
No 4 S Indirect See footnote.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1 Direct
Footnotes
  1. Shares are held by Sofinnova Venture Partners VI, L.P. ("SV VI"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI. Such persons and entities disclaim beneficial ownership of shares held by SV VI except to the extent of any pecuniary interest therein.
  2. Shares held by Sofinnova Venture Partners VI GmbH & Co. KG. ("SV VI KG"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the managing limited partner of SV VI KG, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI KG. Such persons and entities disclaim beneficial ownership of shares held by SV VI KG except to the extent of any pecuniary interest therein.
  3. Shares are held by Sofinnova Venture Affiliates VI, L.P. ("SV VI Affiliates"). Sofinnova Management VI, L.L.C. ("SV VI LLC"), the general partner of SV VI Affiliates, and Michael F. Powell, a director of the issuer, James I. Healy, Alain L. Azan and Eric P. Buatois, the managing members of SV VI LLC, may be deemed to share voting and dispositive power over the shares held by SV VI Affiliates. Such persons and entities disclaim beneficial ownership of shares held by SV VI Affiliates except to the extent of any pecuniary interest therein.